190 related articles for article (PubMed ID: 1863104)
41. Treatment of episodic hyperammonemia in children with inborn errors of urea synthesis.
Brusilow SW; Danney M; Waber LJ; Batshaw M; Burton B; Levitsky L; Roth K; McKeethren C; Ward J
N Engl J Med; 1984 Jun; 310(25):1630-4. PubMed ID: 6427608
[TBL] [Abstract][Full Text] [Related]
42. Sodium benzoate and arginine: alternative pathway therapy in inborn errors of urea synthesis.
Batshaw ML
Prog Clin Biol Res; 1983; 127():69-83. PubMed ID: 6889404
[No Abstract] [Full Text] [Related]
43. Hyperargininemia: clinical course and treatment with sodium benzoate and phenylacetic acid.
Mizutani N; Maehara M; Hayakawa C; Kato T; Watanabe K; Suzuki S
Brain Dev; 1983; 5(6):555-63. PubMed ID: 6670711
[TBL] [Abstract][Full Text] [Related]
44. Renal handling of carnitine in secondary carnitine deficiency disorders.
Stanley CA; Berry GT; Bennett MJ; Willi SM; Treem WR; Hale DE
Pediatr Res; 1993 Jul; 34(1):89-97. PubMed ID: 8356025
[TBL] [Abstract][Full Text] [Related]
45. Identification of 3-methylglutarylcarnitine. A new diagnostic metabolite of 3-hydroxy-3-methylglutaryl-coenzyme A lyase deficiency.
Roe CR; Millington DS; Maltby DA
J Clin Invest; 1986 Apr; 77(4):1391-4. PubMed ID: 3958190
[TBL] [Abstract][Full Text] [Related]
46. Potentiation by piridoxilate of the synthesis of hippurate from benzoate in isolated rat hepatocytes. An approach to the determination of new pathways of nitrogen excretion in inborn errors of urea synthesis.
Coude FX; Coude M; Grimber G; Pelet A; Charpentier C
Clin Chim Acta; 1984 Jan; 136(2-3):211-7. PubMed ID: 6692575
[TBL] [Abstract][Full Text] [Related]
47. Disposition of sodium benzoate in newborn infants with hyperammonemia.
Green TP; Marchessault RP; Freese DK
J Pediatr; 1983 May; 102(5):785-90. PubMed ID: 6842341
[TBL] [Abstract][Full Text] [Related]
48. Determination of acylcarnitines in urine of patients with inborn errors of metabolism using high-performance liquid chromatography after derivatization with 4'-bromophenacylbromide.
Poorthuis BJ; Jille-Vlcková T; Onkenhout W
Clin Chim Acta; 1993 Jul; 216(1-2):53-61. PubMed ID: 8222273
[TBL] [Abstract][Full Text] [Related]
49. Treatment of urea cycle disorders.
Thoene JG
J Pediatr; 1999 Mar; 134(3):255-6. PubMed ID: 10064655
[No Abstract] [Full Text] [Related]
50. Propionylcarnitine excretion is not affected by metronidazole administration to patients with disorders of propionate metabolism.
Burns SP; Iles RA; Saudubray JM; Chalmers RA
Eur J Pediatr; 1996 Jan; 155(1):31-5. PubMed ID: 8750807
[TBL] [Abstract][Full Text] [Related]
51. The effect of intravenous L-carnitine on propionic acid excretion in acute propionic acidaemia.
Böhles H; Lehnert W
Eur J Pediatr; 1984 Nov; 143(1):61-3. PubMed ID: 6510434
[TBL] [Abstract][Full Text] [Related]
52. Quantitation of urinary carnitine esters in a patient with medium-chain acyl-coenzyme A dehydrogenase deficiency: effect of metabolic state and L-carnitine therapy.
Schmidt-Sommerfeld E; Penn D; Kerner J; Bieber LL; Rossi TM; Lebenthal E
J Pediatr; 1989 Oct; 115(4):577-82. PubMed ID: 2795349
[TBL] [Abstract][Full Text] [Related]
53. Treatment of hyperargininemia with sodium benzoate and arginine-restricted diet.
Qureshi IA; Letarte J; Ouellet R; Batshaw ML; Brusilow S
J Pediatr; 1984 Mar; 104(3):473-6. PubMed ID: 6707802
[No Abstract] [Full Text] [Related]
54. Oxidative stress parameters in urine from patients with disorders of propionate metabolism: a beneficial effect of L:-carnitine supplementation.
Ribas GS; Biancini GB; Mescka C; Wayhs CY; Sitta A; Wajner M; Vargas CR
Cell Mol Neurobiol; 2012 Jan; 32(1):77-82. PubMed ID: 21833551
[TBL] [Abstract][Full Text] [Related]
55. Intravenous L-carnitine and acetyl-L-carnitine in medium-chain acyl-coenzyme A dehydrogenase deficiency and isovaleric acidemia.
Van Hove JL; Kahler SG; Millington DS; Roe DS; Chace DH; Heales SJ; Roe CR
Pediatr Res; 1994 Jan; 35(1):96-101. PubMed ID: 8134205
[TBL] [Abstract][Full Text] [Related]
56. Benzoic acid metabolism reflects hepatic mitochondrial function in rats with long-term extrahepatic cholestasis.
Krähenbühl L; Reichen J; Talos C; Krähenbühl S
Hepatology; 1997 Feb; 25(2):278-83. PubMed ID: 9021934
[TBL] [Abstract][Full Text] [Related]
57. Treatment of urea cycle disorders.
Batshaw ML; Monahan PS
Enzyme; 1987; 38(1-4):242-50. PubMed ID: 3326732
[TBL] [Abstract][Full Text] [Related]
58. Urinary profile of L-carnitine and its derivatives in starved normal persons and ACTH injected patients with myopathy.
Suzuki M; Tokuyama K; Kinoshita M
J Nutr Sci Vitaminol (Tokyo); 1983 Jun; 29(3):303-12. PubMed ID: 6312001
[TBL] [Abstract][Full Text] [Related]
59. Urinary carnitine excretion in patients with heart failure.
Matsui S; Sugita T; Matoba M; Murakami E; Takekoshi N; Shinka T; Matsumoto I
Clin Cardiol; 1994 Jun; 17(6):301-5. PubMed ID: 8070147
[TBL] [Abstract][Full Text] [Related]
60. [Carnitine in the treatment of methylmalonic aciduria (MMA)].
Penn D; Schmidt H; Otten A; Schmidt-Sommerfeld E
Monatsschr Kinderheilkd; 1986 Oct; 134(10):758-61. PubMed ID: 2879226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
